Rankings
▼
Calendar
▼
LRMR FY 2011 Earnings Report — Larimar Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
Larimar Therapeutics, Inc.
LRMR
FY 2011 Earnings
Reported December 30, 2011
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
FY 2011
Prior Q
FY 2010
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
-$13M
—
—
—
—
EPS (Diluted)
$-6.07
—
—
—
—
Free Cash Flow
-$12M
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$4.0K
GROSS PROFIT
-$4.0K
R&D Expenses
$11M
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
$2M
Other Expenses
$0
Operating Expenses
$13M
Cost & Expenses
$13M
OPERATING INCOME
-$13M
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
-$3.0K
INCOME BEFORE TAX
-$13M
Income Tax Expense
$0
Net Income from Continuing Ops
-$13M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$13M
Net Income Deductions
-$106.0K
BOTTOM LINE NET INCOME
-$13M
D&A
$4.0K
EBIT
-$13M
EBITDA
-$13M
EPS
-$6
EPS Diluted
-$6
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$13M
Depreciation & Amortization
$4.0K
Stock-Based Compensation
$0
Deferred Income Tax
$0
Other Non-Cash Items
$78.0K
Change in Working Capital
$801.0K
OPERATING CASH FLOW
-$12M
Capital Expenditure
-$35.0K
Acquisitions (Net)
$2.0K
Purchases of Investments
$0
Sales/Maturities of Investments
$0
Other Investing Activities
-$12.0K
NET CASH FROM INVESTING
-$45.0K
Net Debt Issuance
$0
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
$0
NET CASH FROM FINANCING
$10M
FREE CASH FLOW
-$12M
Net Change in Cash
$0
marketcaparena.com
← FY 2012
LRMR Overview